ETHYL (5.ALPHA.)-7,8-DIDEHYDRO-4,5-EPOXY-3-((ETHOXYCARBONYL)OXY)-14-HYDROXY-6-OXOMORPHINAN-17-CARBOXYLATE
UNII QQX84F42Y8
Substance Identification & Data
This profile provides standardized clinical and technical data for Ethyl (5.alpha.)-7,8-didehydro-4,5-epoxy-3-((ethoxycarbonyl)oxy)-14-hydroxy-6-oxomorphinan-17-carboxylate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QQX84F42Y8.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 102272-78-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H23NO8 QMIQRPVWVQHNHL-RWBNYIAVSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Ethyl (5.alpha.)-7,8-didehydro-4,5-epoxy-3-((ethoxycarbonyl)oxy)-14-hydroxy-6-oxomorphinan-17-carboxylate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.